Zobrazeno 1 - 10
of 77
pro vyhledávání: '"I Farská"'
Publikováno v:
Physiological research. 46(1)
Alterations in phospholipid metabolism in blood elements have been proposed as the possible biochemical marker of schizophrenia. In the present study, we investigated the composition and membrane distribution of phospholipids in platelets of drug-fre
Publikováno v:
Ceska a slovenska psychiatrie. 91(5)
The objective of the present work was to evaluate on the basis of the authors' data and data in the literature the role of phospholipase A2 in the pathogenesis of schizophrenia. The authors submit available literature pertaining to the problem as wel
Publikováno v:
European Neuropsychopharmacology. 3:395
Publikováno v:
Clinical Neuropharmacology. 15:293B
Publikováno v:
Neuropsychobiology. 7:12-16
The steady-state values in rats after a second 14-day period of daily subcutaneous administration of imipramine were the same as during the first period; liver demethylation activity rose for up to 3 days and then returned to normal. The imipramine-b
Publikováno v:
International Pharmacopsychiatry. 15:157-165
After the intraperitoneal administration of 0.5 mEq 134 CsCI . kg -1 to mice, the maximum cesium level in the kidney's, heart, lungs and liver was found in the first hour (T 1/2 13 h), in the muscles after 8 h (T 1/2 180 h), in the brain after 24 h (
Publikováno v:
Thrombosis and Haemostasis. 23:593-600
Summary1. The following coagulation changes were found in rats with experimental hypersplenism: a mild prolongation of the recalcification time, shortened times in Quick’s test, a lowered activity in plasma thrombin time and shortened times in the
Publikováno v:
British Journal of Haematology. 16:373-380
Summary: Changes in Factors V and VIII were studied in normal, unilaterally nephrectomized, and splenectomized rats. Adrenaline in a dose of 3 or 6 μg. per 200 g. body weight subcutaneously induced a significant but not very large increase in the ac
Publikováno v:
Activitas nervosa superior. 20(4)
Publikováno v:
Ceskoslovenska psychiatrie. 81(2)